This week, we’re chatting with Haseeb Ahmad, CEO of Purespring Therapeutics, about gene therapies in kidney disease, and with Pahini Pandya, Panakeia CEO, about colorectal cancer biomarkers, the potential of AI in clinical decision-making and how AI can transform workflows in diagnostics.

Times:

03:34 Purespring

24:11 Panakeia Technologies

Purespring Therapeutics

Purespring is a precision nephrology company pioneering first-in-class, targeted genetic therapies designed to preserve kidney function.

The company is focused on transforming the treatment of kidney disease—an area of enormous unmet need, with more than 840m people worldwide living with chronic kidney disease.

P ...